Remedy Names Former EA VP Jean-Charles Gaudechon as CEO

Remedy Names Former EA VP Jean-Charles Gaudechon as CEO

Remedy Entertainment has announced the appointment of Jean-Charles “JC” Gaudechon as its new CEO. Gaudechon, a seasoned leader in the gaming industry, will officially take on the role starting March 1. He succeeds the interim CEO and co-founder, Markus Mäki.

Jean-Charles Gaudechon: A New Era for Remedy

Gaudechon brings over two decades of experience in the global gaming and digital entertainment sectors. Previously, he held senior positions at renowned companies like Electronic Arts (EA) and CCP Games. Most recently, he served as Senior Vice President and Group General Manager at Sleeper, a popular sports application.

Board Chairman’s Statement

Henri Österlund, the chairman of Remedy’s board of directors, expressed enthusiasm about Gaudechon’s appointment. He stated, “I am delighted to announce the appointment of Jean-Charles (JC) Gaudechon to lead Remedy into a phase of profitable growth.” Österlund highlighted Gaudechon’s successful history in growing gaming franchises and managing international studios, noting that he is an ideal fit for Remedy’s current stage.

Gaudechon’s Vision for Remedy

In his first statement as CEO, Gaudechon expressed excitement about joining Remedy at a crucial moment in its development. He emphasized the studio’s unique creative identity and its strong project pipeline.

  • Commitment to protecting Remedy’s uniqueness.
  • Focus on delivering exceptional games.
  • Aims to scale the company for lasting value.

Gaudechon also stressed the importance of connecting with players to earn their trust. He affirmed Remedy’s ambition to become a significant part of the industry’s future by enhancing its independence in game development and publishing.

Relocation and Future Engagement

Gaudechon will be relocating to Finland with his family. He looks forward to collaborating closely with the studio team as they embark on this exciting journey. His leadership is expected to play a crucial role in Remedy’s plans for growth and innovation.